Eduard Sanders/J Acquir Immune Defic Syndr

Modeling the Impact of HIV-1 Nucleic Acid Testing Among Symptomatic Adult Outpatients in Kenya.Hamilton DT, Agutu C, Babigumira JB, van der Elst E, Hassan A, Gichuru E, Mugo P, Farquhar C, Ndung'u T, Sirengo M, Chege W, Goodreau SM, Elder A, Sanders EJ, Graham SM
J Acquir Immune Defic Syndr, (2022). 90:553-561

Semen Bacterial Concentrations and HIV-1 RNA Shedding Among HIV-1-Seropositive Kenyan Men.Korhonen CJ, Srinivasan S, Huang D, Ko DL, Sanders EJ, Peshu NM, Krieger JN, Muller CH, Coombs RW, Fredricks DN, Graham SM
J Acquir Immune Defic Syndr, (2017). 74:250-257

Comparing the novel method of assessing PrEP adherence/exposure using hair samples to other pharmacologic and traditional measures.Baxi SM, Liu A, Bacchetti P, Mutua G, Sanders EJ, Kibengo FM, Haberer JE, Rooney J, Hendrix CW, Anderson PL, Huang Y, Priddy F, Gandhi M
J Acquir Immune Defic Syndr, (2015). 68:13-20

Identifying at-risk populations in Kenya and South Africa: HIV incidence in cohorts of men who report sex with men, sex workers, and youth.Price MA, Rida W, Mwangome M, Mutua G, Middelkoop K, Roux S, Okuku HS, Bekker LG, Anzala O, Ngugi E, Stevens G, Chetty P, Amornkul PN, Sanders EJ
J Acquir Immune Defic Syndr, (2012). 59:185-93